Compared with the control tissues, a marked upregulation in SIX1 expression levels was observed in the liver, colon, breast, ovary, kidney, lung, and prostate tumor tissues, while a slight downregulation was observed in thyroid cancer tissues (Figure 1A). The gene discussed is SIX1; the disease is thyroid gland carcinoma.